NEWS & INSIGHTS

Latest News
Huadong Medicine and Exscientia enter co-development partnership to accelerate oncology drug discovery through artificial intelligence
Read Now

All

Huadong Medicine and Exscientia enter co-development partnership to accelerate oncology drug discovery through artificial intelligence

READ MORE

Exscientia Featured in TECH TRACK 100 report on Britain's Fastest Growing Tech Companies

READ MORE

Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats

READ MORE

Exscientia raises $60 million in Series C financing round led by Novo Holdings

READ MORE

SRI International and Exscientia Enter Collaboration to Accelerate Drug Discovery Through Automation and Artificial Intelligence

READ MORE

Exscientia announces joint initiative to identify COVID-19 drugs with Diamond Light Source and Scripps Research

READ MORE

TheGuardian focuses on Exscientia's screen of 15,000 drugs in search for a coronavirus treatment

READ MORE

Artificial Intelligence and Coronavirus Treatments

READ MORE

Financial Times : Read the article detailing Exscientia's work on the first AI-designed drug to enter clinical trials.

READ MORE
  • <<
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • >>